Shifting sands: Changing regional and gender-specific patterns of HIV/aids mortality in Canada, 1987 to 2008

Canadian Journal of Public Health

Volumn 103, Issue 3, 2012, Pages 202-206

  Belvedere, Lindsay M ^a   Miller, Caroline L ^a   Hogg, Robert S ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Aids; Canada; Demography; HIV; Mortality

Indexed keywords

EID: 84864672627     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403813     Document Type: Article

References (26)

1. Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, et al. Cohort profile: The Canadian Observational Cohort collaboration. Int J Epidemiol 2011;40(1):25-32.
2. Public Health Agency of Canada. Summary: Estimates of HIV prevalence and incidence in Canada, 2008. Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/pdf/estimat08-eng.pdf (Accessed April 7, 2010).
3. British Columbia Centre for Excellence in HIV/AIDS. Therapeutic guidelines: Antiretroviral treatment of adult HIV infection, 2009. Available at: http://www.cfenet.ubc.ca/sites/default/files/uploads/docs/Adult_Therapeu-tic_Guidelines.pdf (Accessed April 7, 2010).
4. Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2009;53(1):124-130.
5. Beck EJ, Mays N, Whiteside AW, Zuniga JM (Eds.). The HIV Pandemic: Local and Global Implications. New York, NY: Oxford University Press, 2006.
6. Hogg RS, Heath KV, Strathdee SA, Montaner JSG, O'Shaughnessy MV, Schechter MT. HIV/AIDS mortality in Canada: Evidence of gender, regional and local area differentials. AIDS 1996;10:889-894.
7. Hogg RS, Schechter MT, Montaner JSG, Goldstone I, Craib K, O'Shaughnessy MV. Impact of HIV infection and AIDS on death rates in British Columbia and Canada. CMAJ 1994;150(5):711-717.
8. Weber AE, Hogg RS. Morbidity and mortality related to human immunodeficiency virus in Canadian men and women, 1987-94. Can J Public Health 1999;90(2):127-132.
9. Statistics Canada. Causes of Death 84-208-XIE. Available at: http://www.stat-can.gc.ca/bsolc/olc-cel/olc-cel?catno=84-208-x&lang=eng (Accessed August 22, 2011).
10. US Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision (ICD-9), 2009. Available at: http://www.cdc.gov/ nchs/icd/icd9.htm (Accessed August 22, 2011).
11. th revision, 2005. Available at: http://apps.who.int/classifications/apps/icd/icd10online2005/fr-icd.htm (Accessed August 22, 2011).
12. Statistics Canada. Table 051-0001: Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons unless otherwise noted). Available at: http://cansim2.statcan.gc.ca/cgi-win/cnsmcgi.exe?Lang=E&RootDir=CII/&ResultTemplate=CII/CII___&Array_Pick= 1&ArrayId=0510001 (Accessed August 22, 2011).
13. rd edition. Philadelphia, PA: Lippincott Williams and Wilkins, 2008.
14. Ahmad OE, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates: A New WHO Standard (GPE Discussion Paper Series: No. 31). Geneva, Switzerland: World Health Organization, 2000.
15. Hogg RS, Yip B, Kully C, Craib KJP, O'Shaughnessy MV, Schechter MT, Mon-taner JSG. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 1999;160(5):659-665.
16. Yoong D. Access and coverage of HIV medications across Canada, 2009. Available at: http://www.hivclinic.ca/main/drugs_reimbuse_files/Provincial%20 Coverage%20of%20HIV%20medications.pdf (Accessed August 22, 2011).
17. Krusi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy 2010;21:4-9.
18. Miller CL, Spittal PM, Wood E, Chan K, Schechter MT, Montaner JSG, et al. Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations. AIDS Care 2006;18(8):968-976.
19. Tyndall MW, McNally M, Lai C, Zhang R, Wood E, Kerr T, et al. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: Access, adherence and outcomes. Int J Drug Policy 2006;18:281-287.
20. Public Health Agency of Canada. HIV/AIDS Epi Updates, November 2007. Ottawa, ON: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, PHAC, 2007.
21. BC Centre for Disease Control. Annual Update Report 2008: HIV and AIDS. Vancouver, BC: STI/HIV Prevention and Control, BCCDC, 2008.
22. Boulos D, Yan P, Schanzer D, Remis RS, Archibald MD. Estimates of HIV prevalence and incidence in Canada, 2005. Can Commun Dis Rep 2006;32(15):165-174.
23. British Columbia Vital Statistics Agency. Selected vital statistics and health status indicators. One hundred thirty-eighth Annual report 2009 vital statistics. Victoria, BC: Ministry of Health Services, 2009.
24. Plitt SS, Gratrix J, Hewitt S, Conroy P, Parnell T, Lucki B, et al. Seroprevalence and correlates of HIV and HCV among injecting drug users in Edmonton, Alberta. Can J Public Health 2010;101(1):50-55.
25. Au-Yeung CG, Anema A, Chan K, Yip B, Montaner JSG, Hogg RS. Physician's manual reporting underestimates mortality: Evidence from a population-based HIV/AIDS treatment program. BMC Public Health 2010;10:64.
26. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41(2):194-200.